Subcellular MLH1 protein as first in class biomarker for CDK4/6 response in endocrine resistant ER+/HER2-breast cancer

被引：0
|
作者：
Mazumder, Aloran
Oropeza, Elena
Punturi, Nindo
Haricharan, Svasti
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5129
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer
    Belli, Stefania
    Esposito, Daniela
    Allotta, Alessandra
    Servetto, Alberto
    Ciciola, Paola
    Pesapane, Ada
    Ascione, Claudia M.
    Napolitano, Fabiana
    Di Mauro, Concetta
    Vigliar, Elena
    Iaccarino, Antonino
    De Angelis, Carmine
    Bianco, Roberto
    Formisano, Luigi
    NPJ BREAST CANCER, 2023, 9 (01)
  • [32] Response of persistent metastatic ER+/Her2-breast cancer treated with fulvestrant plus enzalutamide
    Richer, Jennifer
    Spoelstra, Nicole
    Winchester, Alyse
    Wulfkuhlue, Julia
    Gallagher, Rosa
    Sams, Sharon
    Vidal, Gregory
    Kabos, Peter
    Diamond, Jennifer
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadded, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Petricoin, Emanuel
    Elias, Anthony
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk
    Sarkar, Swarnavo
    Schechter, Clyde
    Kurian, Allison W.
    Caswell-Jin, Jennifer L.
    Jayasekera, Jinani
    Mandelblatt, Jeanne S.
    NPJ BREAST CANCER, 2025, 11 (01)
  • [34] CDK4/6 Inhibitors for Metastatic HR+/HER2-Breast Cancer: Clinico-Pathological Analysis for Determinants of Response
    Maruthi, Vijaya Kadam
    Schultz, Emily
    Knudsen, Erik
    Witkiewicz, Agnieszka
    Hamilton, Deanna
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 136 - 138
  • [35] CDK4/6 Inhibitors for Metastatic HR+/HER2-Breast Cancer: Clinico-Pathological Analysis for Determinants of Response
    Maruthi, Vijaya Kadam
    Schultz, Emily
    Knudsen, Erik
    Witkiewicz, Agnieszka
    Hamilton, Deanna
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 136 - 138
  • [36] Discovery of BTX-9341, a bifunctional degrader of CDK4 and CDK6 for HR+/HER2-breast cancer
    Majeski, Hannah
    Okano, Akinori
    Chahal, Kirti
    Pasis, Angela
    Carlson, Casey
    Shakya, Arvind
    Liu, Qiao
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah
    CANCER RESEARCH, 2024, 84 (09)
  • [37] PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer
    Chen, Anran
    Kim, Beom-Jun
    Mitra, Aparna
    Vollert, Craig T.
    Lei, Jonathan T.
    Fandino, Diana
    Anurag, Meenakshi
    Holt, Matthew V.
    Gou, Xuxu
    Pilcher, Jacob B.
    Goetz, Matthew P.
    Northfelt, Donald W.
    Hilsenbeck, Susan G.
    Marshall, C. Gary
    Hyer, Marc L.
    Papp, Robert
    Yin, Shou-Yun
    De Angelis, Carmine
    Schiff, Rachel
    Fuqua, Suzanne A. W.
    Ma, Cynthia X.
    Foulds, Charles E.
    Ellis, Matthew J.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (10) : 1494 - 1510
  • [38] Discovery of BTX-9341, a bifunctional degrader of CDK4 and CDK6 for HR+/HER2-breast cancer
    Majeski, Hannah
    Okano, Akinori
    Chahal, Kirti
    Pasis, Angela
    Carlson, Casey
    Shakya, Arvind
    Liu, Qiao
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah
    CANCER RESEARCH, 2024, 84 (06)
  • [39] Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2-Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2-Breast Cancer
    Rosswag, Sven
    Cotarelo, Cristina L.
    Pantel, Klaus
    Riethdorf, Sabine
    Sleeman, Jonathan P.
    Schmidt, Marcus
    Thaler, Sonja
    CANCERS, 2021, 13 (08)
  • [40] The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations
    Soria-Bretones, Isabel
    Thu, Kelsie L.
    Silvester, Jennifer
    Cruickshank, Jennifer
    El Ghamrasni, Samah
    Ba-alawi, Wail
    Fletcher, Graham C.
    Kiarash, Reza
    Elliott, Mitchell J.
    Chalmers, Jordan J.
    Elia, Andrea C.
    Cheng, Albert
    Rose, April A. N.
    Bray, Mark R.
    Haibe-Kains, Benjamin
    Mak, Tak W.
    Cescon, David W.
    SCIENCE ADVANCES, 2022, 8 (36)
12345